Board of Directors of the Fredun Pharmaceuticals Limited at its meeting held on May 16, 2022 approved the Recommended Final Dividend at 7% per Equity Share having face value of INR 10/- each for the Financial Year 2021-22; subject to the approval of the shareholders at the upcoming 35th Annual General Meeting of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
812.8 INR | +1.50% | +2.39% | -6.43% |
05-10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
05-08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-6.43% | 45.08M | |
+45.95% | 754B | |
+40.95% | 630B | |
-6.00% | 352B | |
+19.68% | 331B | |
+9.52% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+6.07% | 164B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year 2021-22